Dr. Dana Orange, MD, MSc, is an Assistant Attending Rheumatologist at HSS and Assistant Professor at Rockefeller University. She received her medical degree from Weill Cornell Medical College, Cornell University, and her MSc from Rockefeller University. She completed her Internal Medicine Residency at NewYork-Presbyterian Hospital and her Rheumatology fellowship at HSS. Dr. Orange's research aims to understand the molecular underpinnings of symptoms of rheumatoid arthritis such as pain, morning stiffness, and flares
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Assistant Attending Rheumatologist, Hospital for Special Surgery
Assistant Professor of Clinical Investigation, Rockefeller University
Academic Committee, Rockefeller University Hospital
Advisory Committee for Clinical and Translational Science, Co-Chair, Rockefeller University
American College of Rheumatology
American College of Rheumatology Annual Meeting Co-Chair, Rheumatoid Arthritis Etiology and Pathogenesis
Clinical Research Review Panel, Co-Chair, Hospital for Special Surgery
Henry Kunkel Society
Medical Advisory Committee, Autoimmune Polyglandular Syndrome-1 Foundation
New York Arthritis Foundation, Board Member
Pilot Award Review Committee, Rockefeller University
Rockefeller University Hospital Credentials Committee
Board Certified, Internal Medicine and Rheumatology
Bernard Schwartz Physician Scientist Award, 2019
Beth and Ravenel Curry Clinical Scholar, 2011
Charles Christian Award for Musculoskeletal Research, 2009
Department of Medicine Fellow Award Finalist, 2009
Alpha Omega Alpha, 2002
David and Gladys Drusin Memorial Prize for scholastic achievement in medicine and those intangible qualities associated with a good physician, 2002
Gustavo Cudkowicz Memorial Prize in Immunobiology, 2002
Phi Beta Kappa, 1996
Doctor of Medicine, Weill Medical College of Cornell University, New York, NY
Masters of Translational Research, The Rockefeller University, New York, NY
Internal Medicine Resident, NewYork-Presbyterian Hospital, Cornell Campus
Internal Medicine Resident, New York Presbyterian Hospital, Cornell Campus
Rheumatology Fellow, Hospital for Special Surgery
Rheumatoid Arthritis Forum, Karolinska Institute, Stockholm, Sweden
Fibroblast: State of the Art Seminar, University of Zurich
15th International Symposium, Korean College of Rheumatology, Seoul, Korea
Molecular Interception of Disease Symposium, Sidra Research Institute, Doha, Qatar
FNIH Biomarkers Consortium, Inflammation and Immunity Steering Committee Meeting
Schroeder Arthritis Institute Seminar, University of Toronto
Immune Tolerance Network, Control Rheumatoid Arthritis Meeting
J&J Innovation Lab: Making Precision Medicine a Reality in Immune Mediated Disease
NYU Langone Seminar in Advanced Rheumatology
Our group focuses on characterizing the molecular mechanisms that underlie phenotypes of rheumatoid arthritis (RA). In previous studies we have used machine learning to integrate rheumatoid arthritis gene expression profiles with histology features to provide insight into RA disease subsets (Arthritis and Rheumatol, 2018) and have noted the persistence of histologic and transcriptional evidence of subclinical synovial inflammation in RA patients in clinical remission (Arthritis and Rheumatol, 2019). We have also developed methods to empower patients to participate in dense longitudinal genomics studies from home and used this approach to gain insights into the immune events that led to rheumatoid arthritis flares (NEJM, 2020).
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of May 31, 2023, Dr. Orange reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.